MediWound (MDWD) Total Non-Current Liabilities (2013 - 2026)
MediWound (MDWD) posted quarterly Total Non-Current Liabilities of $16.9 million for Q4 2025, up 7.04% year-over-year from $15.8 million in Q4 2024, and down 6.1% quarter-over-quarter from $18.0 million in Q3 2025.
MediWound (MDWD) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
MediWound's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $16.9 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities rose 7.04% year-over-year to $16.9 million; the TTM figure through Dec 2025 stood at $16.9 million (up 7.04% YoY), while the FY2025 annual figure was $16.9 million, up 7.04% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $16.9 million, down from $18.0 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $27.0 million in Q4 2022, with the low at $11.4 million in Q1 2023.
- The 5-year median for Total Non-Current Liabilities is $15.9 million (2024), against an average of $15.8 million.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities soared 98.79% in 2022, then sank 38.11% in 2023.
- MediWound's Total Non-Current Liabilities stood at $13.6 million in 2021, then jumped by 98.79% to $27.0 million in 2022, then sank by 38.11% to $16.7 million in 2023, then dropped by 5.6% to $15.8 million in 2024, then gained by 7.04% to $16.9 million in 2025.
- Business Quant data shows MDWD's Total Non-Current Liabilities at $16.9 million in Q4 2025, $18.0 million in Q3 2025, and $17.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | 3.92 Bn |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 1.88 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | 724.15 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.17 Bn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 9.32 Bn |
| 10 | MediWound | 170.71 Mn | 139.71 Mn | 337,000.00 | 17.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.69 Mn |
| Dec 31, 2025 | 16.92 Mn |
| Sep 30, 2025 | 18.01 Mn |
| Jun 30, 2025 | 17.81 Mn |
| Mar 31, 2025 | 15.90 Mn |
| Dec 31, 2024 | 15.80 Mn |
| Sep 30, 2024 | 14.92 Mn |
| Jun 30, 2024 | 16.82 Mn |
| Mar 31, 2024 | 16.84 Mn |
| Dec 31, 2023 | 16.74 Mn |
| Sep 30, 2023 | 16.63 Mn |
| Jun 30, 2023 | 11.45 Mn |
| Mar 31, 2023 | 11.43 Mn |
| Dec 31, 2022 | 27.05 Mn |
| Sep 30, 2022 | 17.92 Mn |
| Jun 30, 2022 | 12.93 Mn |
| Mar 31, 2022 | 13.17 Mn |
| Dec 31, 2021 | 13.61 Mn |
| Sep 30, 2021 | 14.03 Mn |
| Jun 30, 2021 | 14.43 Mn |